AG
IRWD icon

AlphaSimPlex Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

AlphaSimPlex Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$109K Hold
10,510
– – 1.1% 35
2022
Q2 		$121K Buy
+10,510
New +$124K 0.86% 47

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AlphaSimPlex Group's IRWD Position: Q3 2022 in Review

AlphaSimPlex Group held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2022 at 10,510 shares worth $109K. The position accounts for 1.1% of the portfolio, ranked #35.

AlphaSimPlex Group first reported a position in IRWD in Q2 2022 and has held it in 2 quarters since. The position peaked at $121K in Q2 2022. 245 funds tracked by Wall St. Rank hold IRWD as of Q3 2022.

  • AlphaSimPlex Group held 10,510 shares of Ironwood Pharmaceuticals worth $109K as of Q3 2022.
  • AlphaSimPlex Group left its Ironwood Pharmaceuticals share count unchanged in Q3 2022.
  • Ironwood Pharmaceuticals made up 1.1% of AlphaSimPlex Group's portfolio in Q3 2022, its #35 holding.
  • AlphaSimPlex Group first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 2 quarters since.
  • AlphaSimPlex Group's Ironwood Pharmaceuticals position peaked at $121K in Q2 2022.
  • 245 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2022.

Based on AlphaSimPlex Group's 13F filing for Q3 2022, filed 8 Nov 2022.